IMPACT [gngm]
Community Trial [resa]
Pharmacological Treatment [topp]
Individual [popg]
Metabolic syndrome [dsyn]
findings [ftcn]
Health [idcn]
Heart [bpoc]
Program [cnce]
Introduction [hlca]
pharmacologic therapy [ftcn]
Step [cnce]
Management [ocac]
Individual [popg]
Metabolic syndrome [dsyn]
Life Style [socb]
Modification [ftcn]
Alone [qnco]
Therapeutic [topp]
Goals [inpr]
Present [qnco]
Study [mnob]
Aim [idcn]
To [qlco]
Evaluate [ftcn]
Efficacy [qlco]
Comprehensive [qlco]
interventions [hlca]
Pharmacological Treatment [topp]
Individual [popg]
Metabolic syndrome [dsyn]
Material [sbst]
Methods [inpr]
Cross-Sectional Survey [resa]
Population [qnco]
Based [ftcn]
Examined [fndg]
Sample [sbst]
Adults [aggp]
conducting [inbe]
Community Trial [resa]
Physical Examination [hlca]
Blood sampling [diap]
Data [idcn]
demographic [ocdi]
Characteristics [qlco]
Medical [ftcn]
Status [qlco]
History [ocdi]
medication use [fndg]
Obtained [ftcn]
Pharmacological Treatment [topp]
Metabolic syndrome [dsyn]
Components [mnob]
Result [ftcn]
Most [qnco]
Common [qnco]
Pharmacologic Agent [phsu]
Individual [popg]
Metabolic syndrome [dsyn]
Beta-Blockers [phsu]
Lipid lowering agents [phsu]
intervention [hlca]
Prevalence [qnco]
Metabolic syndrome [dsyn]
High [qlco]
Women [popg]
Men [popg]
Before [tmco]
Community Trial [resa]
intervention [hlca]
Area [geoa]
P NOS [aapp, imft]
Conclusions [idcn]
Found [qnco]
Increase [ftcn]
Medication [phsu]
To [qlco]
Control [grup]
Blood Pressure [orgf]
Dyslipidaemia [dsyn]
Individual [popg]
Metabolic syndrome [dsyn]
intervention [hlca]
Area [geoa]
Population [qnco]
Approach [spco]
High approach [spco]
Risk [qlco]
considered [idcn]
Community Trial [resa]
Prevention [topp]
Control [grup]
Non [ftcn]
Communicable Diseases [dsyn]
